CClinicalTrials.gg
Status unknownNCT04005300Updated Dec 29, 2020

Application of Prophylactic Low Calorie Feeding in Critically Ill Patients With High-risk Refeeding Syndrome

An interventional study of standard enteral nutrition and restricted enteral nutrition in Critical Illness, sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. Status unknown at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2020-12-29.

Sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Dec 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Critically ill patients with high-risk nutrition are often at risk of refeeding syndrome(RFS), that the incidence of RFS is as high as 30-50%. It is sure that patients with refeeding syndrome were treated with restrictive enteral nutrition, but the definition of refeeding syndrome is not uniform, and there is still a lack of awareness high-risk patients of RFS to receiving early empirical low-calorie feeding intervention. So, we designed the study which is divided into three stages. Firstly, the monitoring rate of RFS was reviewed to evaluate the incidence of RFS in general ICU. Secondly, the best diagnostic criteria of RFS were prospectively defined. Finally, on this basis, it is assessed whether early low-calorie feeding could improve prognosis in high-risk patients with RFS.

Read the detailed description

Stage 1: the monitoring rate of re-feeding syndrome in our department was reviewed to evaluate the incidence of re-feeding syndrome in severe patients,which is not described in detail; Stage 2:This part is a prospective observational study,divided into two group,that is, RFS group(their serum phosphate concentration decreased to below 0.87 mmol/L within 72 h after starting nutritional support and the biological variation needed to be greater than 30% decrease from any concentration previously recorded), which is divided into three sub-group(Group 1 that a drop of >0.16 mmol/L from any previous measurement, to below 0.65 mmol/L within 72 h after starting nutritional support, Group 2 that their serum phosphate concentration decreased to below 0.87 mmol/L within 72 h after starting nutritional support and the biological variation needed to be greater than 30% decrease from any concentration previously recorded, and Group 3 that their serum phosphate concentration decreased to below 0•32 mmol/L within 72 h after starting nutritional support.), and nRFS group(non-RFS that the serum phosphate do not up to the criteria). And the RFS group will be receiving the low-calorie feeding intervention, the nRFS group will be receiving the standard feeding according to the ASPEN guideline of 2016.

Stage 3: On this basis of stage 2, it is assessed whether early low-calorie feeding could improve prognosis in high-risk patients with RFS who was defined in NICE(National institute for the health and care excellence).The part of stage 3, divided into two groups that standard calorie feeding group and low calorie feeding group, aims to assess whether early low-calorie feeding could improve prognosis in high-risk patients with RFS.

02

Conditions studied

  • Critical Illness

Browse trials for

Keywords

  • Refeeding syndrome
  • Enteral nutrition
  • Critical illness
03

In context

Critical Illness

1,881 studies on the registry are indexed under Critical Illness; 462 are open to participants now.

This study's planned enrollment of 300 is above the median of 90 across 979 interventional studies indexed under Critical Illness.

Browse Critical Illness studies →

Lead sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University is the lead sponsor of 1,058 studies on the registry; 511 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Critically ill patients at least 18 years old;
  • No history of enteral nutrition or parenteral nutrition within 1 week before ICU admission or ICU admission within 1 week;
  • Mechanical ventilation patients requiring enteral nutrition support for >72h

Exclusion criteria

Exclusion Criteria:

  • refuse to join this study;
  • enteral nutrition support for less than 3 days or have enteral nutrition contraindication;
  • less than 18 years old;
  • artificial nutrition (enteral/parenteral nutrition) has been applied to patients before admission;
  • other factors of hypophosphatemia: continuous hemodialysis, recent parathyroidectomy, or hyperphosphatemia after treatment;
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Care provider)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    low calorie feeding group

    Enteral nutrition was fed at 10-20kcal/kg/d for the first three days before identifying the refeeding syndrome

    Dietary Supplement: restricted enteral nutrition

  • Active comparator
    standard calorie feeding group

    Enteral nutrition was fed at 500-750kcal/d for the first three days before identifying the refeeding syndrome

    Dietary Supplement: standard enteral nutrition

  • No intervention
    RFS group

    The definition of RFS is that serum phosphate concentration decreased to below 0.87 mmol/L within 72 h after starting nutritional support and the biological variation needed to be greater than 30% decrease from any concentration previously recorded. And it is divided into three sub-group that is Group 1 that a drop of \>0.16 mmol/L from any previous measurement, to below 0.65 mmol/L within 72 h after starting nutritional support, Group 2 that their serum phosphate concentration decreased to below 0.87 mmol/L within 72 h after starting nutritional support and the biological variation needed to be greater than 30% decrease from any concentration previously recorded, and Group 3 that their serum phosphate concentration decreased to below 0•32 mmol/L within 72 h after starting nutritional support.

  • No intervention
    nRFS group

    It is not up to the RFS definition

Interventions

  • Dietary supplementstandard enteral nutrition

    Enteral nutrition was treated within 48 hours after ICU and the calories were 500-750kcal/d

  • Dietary supplementrestricted enteral nutrition

    Enteral nutrition was treated within 48 hours after ICU and the calories were 10-20kcal/kg/d for 3 days

06

What researchers measure

Primary outcomes

  1. The best diagnostic criteria for refeeding syndrome

    Evaluate the best timing for intervention according to the lowest and the decline of serum phosphate

    Time frame: 1 month mortality and the duration of mechanical ventilation

  2. the incidence of refeeding syndrome

    only according to serum phosphate standard

    Time frame: 3 day after treated with nutrition

Secondary outcomes

  1. duration of mechanical ventilation

    The duration of mechanical ventilation in General ICU of our department in the same time admitted to ICU

    Time frame: 30 days

  2. survival rate

    including discharge from hospital and ICU

    Time frame: 28 days

  3. occurrence of complications

    including feeding intolerance, electrolyte disturbance

    Time frame: 7 days

07

Study locations

1 of 1 sites recruiting
  • Second affiliated hospital, Zhejiang university school of medicine
    Hangzhou, Zhejiang 310052, China
    Recruiting
08

References and documents

Publications

  • Doig GS, Simpson F, Heighes PT, Bellomo R, Chesher D, Caterson ID, Reade MC, Harrigan PW; Refeeding Syndrome Trial Investigators Group. Restricted versus continued standard caloric intake during the management of refeeding syndrome in critically ill adults: a randomised, parallel-group, multicentre, single-blind controlled trial. Lancet Respir Med. 2015 Dec;3(12):943-52. doi: 10.1016/S2213-2600(15)00418-X. Epub 2015 Nov 18. PubMed 26597128 ↗
  • Rio A, Whelan K, Goff L, Reidlinger DP, Smeeton N. Occurrence of refeeding syndrome in adults started on artificial nutrition support: prospective cohort study. BMJ Open. 2013 Jan 11;3(1):e002173. doi: 10.1136/bmjopen-2012-002173. PubMed 23315514 ↗

Individual participant data

Plan to share: Yes — One year after the article was published, and the opening lasted for one year

Supporting information: Study protocol, Sap, Csr

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04005300
Lead sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Responsible party
Sponsor
First posted
Jul 2, 2019
Start date
Jul 1, 2019
Primary completion
Aug 1, 2020
Completion
Aug 1, 2021 (estimated)
Last update
Dec 29, 2020

Study contacts

kongmiao lu, master
Contact
lukongmiao123@163.com
18268061252
man huang, phD
Contact
man huang, phD
principal investigator · Second affiliated hospital, Zhejiang university school of medicine
yunlong wu, master
study director · Second affiliated hospital, Zhejiang university school of medicine

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion